Hemangioblastoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Hemangioblastoma

View Main Condition: Brain Tumor

What is the definition of Hemangioblastoma?
A Hemangioblastoma is a benign, highly vascular tumor that can occur in the brain, spinal cord, and retina (the light-sensitive tissue that lines the back of the eye). This tumor accounts for about 2% of brain tumors. As it enlarges, it presses on the brain and can cause neurological symptoms, such as headaches, weakness, sensory loss, balance and coordination problems, and/or hydrocephalus (a buildup of spinal fluid in the brain). Most Hemangioblastomas occur sporadically. However, some people develop Hemangioblastomas as part of a genetic syndrome called von Hippel-Lindau syndrome. These people usually develop multiple tumors within the brain and spinal cord over their lifetime.
What are the alternative names for Hemangioblastoma?
  • Hemangioblastoma
Who are the top Hemangioblastoma Local Doctors?
Elite in Hemangioblastoma
Ophthalmology | Oncology
Elite in Hemangioblastoma
Ophthalmology | Oncology
Referral may be required

Ophthalmology - Wills Eye Hospital

840 Walnut Street, Floor 10, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Carol Shields is an Ophthalmologist and an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Hemangioblastoma. She is also highly rated in 50 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.

Distinguished in Hemangioblastoma
Neurosurgery
Distinguished in Hemangioblastoma
Neurosurgery
Referral may be required
1295 Northwest 14th Street, 
Miami, FL 
Languages Spoken:
English, French, Italian, Spanish
Accepting New Patients
Offers Telehealth

Allan Levi is a Neurosurgery provider practicing medicine in Miami, Florida. Dr. Levi is rated as a Distinguished provider by MediFind in the treatment of Hemangioblastoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Meningocele, Cervical Spondylosis, Spondylolisthesis, Laminectomy, and Spinal Fusion. Dr. Levi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hemangioblastoma
Elite in Hemangioblastoma
Referral may be required

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
Languages Spoken:
English
Offers Telehealth

Eric Jonasch is an Oncologist practicing medicine in Cary, North Carolina. Dr. Jonasch is rated as an Elite provider by MediFind in the treatment of Hemangioblastoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Hemangioblastoma, Chromophobe Renal Cell Carcinoma, Hypothalamic Hamartomas, and Nephrectomy.

What are the latest Hemangioblastoma Clinical Trials?
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification

Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Exploratory Study of [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

Summary: This is an exploratory study to assess \[18F\]PT2385 Positron Emission Tomography/Computed Tomography (PET/CT) in patients with renal cell carcinoma (RCC). This is an open-label, nontherapeutic trial. The main objective is to correlate hypoxia-inducible factor-2alpha (HIF2α) levels as determined by an investigational \[18F\]PT2385 PET/CT scan with the levels on subsequently obtained tissue by HIF2...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center